Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice
The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has been significant interest in investigating the potential role of this receptor in psychiatric disorders including depression, anxiety, and schi...
Saved in:
| Published in | Behavioural brain research Vol. 360; pp. 270 - 278 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
15.03.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0166-4328 1872-7549 1872-7549 |
| DOI | 10.1016/j.bbr.2018.12.019 |
Cover
| Abstract | The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has been significant interest in investigating the potential role of this receptor in psychiatric disorders including depression, anxiety, and schizophrenia. Behaviors of 5-HT7 +/+ (wild-type or WT) and 5-HT7 -/- (receptor knockout or KO) mice were compared across 10 different assays (7 for anxiety, 1 for depression, 2 for psychosis) to identify differences that could indicate clinical potential for 5-HT7 receptor antagonism. Evaluation of KO vs. WT mice demonstrated significant differences between the genotypes in the fear conditioning, shock-probe burying, novelty-suppressed feeding, punishment memory, forced swim test, and d-amphetamine hyperactivity assays. There was not consistency in either the direction of behavioral effects across genotypes or across assays. Thus, data from these behavioral assays did not uniformly support the idea that 5-HT7 receptors constitute an important drug target for these psychiatric disorders. The present findings are generally congruent with the mixed results in the literature on the behaviors of 5-HT7 -/-mice and with the data on effects of 5-HT7 receptor antagonists in rodent models that detect activity of anxiolytic, antidepressant, and antipsychotic effects. |
|---|---|
| AbstractList | The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has been significant interest in investigating the potential role of this receptor in psychiatric disorders including depression, anxiety, and schizophrenia. Behaviors of 5-HT7 +/+ (wild-type or WT) and 5-HT7 -/- (receptor knockout or KO) mice were compared across 10 different assays (7 for anxiety, 1 for depression, 2 for psychosis) to identify differences that could indicate clinical potential for 5-HT7 receptor antagonism. Evaluation of KO vs. WT mice demonstrated significant differences between the genotypes in the fear conditioning, shock-probe burying, novelty-suppressed feeding, punishment memory, forced swim test, and d-amphetamine hyperactivity assays. There was not consistency in either the direction of behavioral effects across genotypes or across assays. Thus, data from these behavioral assays did not uniformly support the idea that 5-HT7 receptors constitute an important drug target for these psychiatric disorders. The present findings are generally congruent with the mixed results in the literature on the behaviors of 5-HT7 -/-mice and with the data on effects of 5-HT7 receptor antagonists in rodent models that detect activity of anxiolytic, antidepressant, and antipsychotic effects.The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has been significant interest in investigating the potential role of this receptor in psychiatric disorders including depression, anxiety, and schizophrenia. Behaviors of 5-HT7 +/+ (wild-type or WT) and 5-HT7 -/- (receptor knockout or KO) mice were compared across 10 different assays (7 for anxiety, 1 for depression, 2 for psychosis) to identify differences that could indicate clinical potential for 5-HT7 receptor antagonism. Evaluation of KO vs. WT mice demonstrated significant differences between the genotypes in the fear conditioning, shock-probe burying, novelty-suppressed feeding, punishment memory, forced swim test, and d-amphetamine hyperactivity assays. There was not consistency in either the direction of behavioral effects across genotypes or across assays. Thus, data from these behavioral assays did not uniformly support the idea that 5-HT7 receptors constitute an important drug target for these psychiatric disorders. The present findings are generally congruent with the mixed results in the literature on the behaviors of 5-HT7 -/-mice and with the data on effects of 5-HT7 receptor antagonists in rodent models that detect activity of anxiolytic, antidepressant, and antipsychotic effects. The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has been significant interest in investigating the potential role of this receptor in psychiatric disorders including depression, anxiety, and schizophrenia. Behaviors of 5-HT7 +/+ (wild-type or WT) and 5-HT7 -/- (receptor knockout or KO) mice were compared across 10 different assays (7 for anxiety, 1 for depression, 2 for psychosis) to identify differences that could indicate clinical potential for 5-HT7 receptor antagonism. Evaluation of KO vs. WT mice demonstrated significant differences between the genotypes in the fear conditioning, shock-probe burying, novelty-suppressed feeding, punishment memory, forced swim test, and d-amphetamine hyperactivity assays. There was not consistency in either the direction of behavioral effects across genotypes or across assays. Thus, data from these behavioral assays did not uniformly support the idea that 5-HT7 receptors constitute an important drug target for these psychiatric disorders. The present findings are generally congruent with the mixed results in the literature on the behaviors of 5-HT7 -/-mice and with the data on effects of 5-HT7 receptor antagonists in rodent models that detect activity of anxiolytic, antidepressant, and antipsychotic effects. |
| Author | Degroot, Aldemar Gleason, Scott D. Balcer, Olivia M. Seager, Matthew A. Witkin, Jeffrey M. Rasmussen, Kurt Maxwell, Julia K. Nomikos, George Li, Xia |
| Author_xml | – sequence: 1 givenname: Olivia M. surname: Balcer fullname: Balcer, Olivia M. – sequence: 2 givenname: Matthew A. surname: Seager fullname: Seager, Matthew A. – sequence: 3 givenname: Scott D. surname: Gleason fullname: Gleason, Scott D. – sequence: 4 givenname: Xia surname: Li fullname: Li, Xia – sequence: 5 givenname: Kurt surname: Rasmussen fullname: Rasmussen, Kurt – sequence: 6 givenname: Julia K. surname: Maxwell fullname: Maxwell, Julia K. – sequence: 7 givenname: George surname: Nomikos fullname: Nomikos, George – sequence: 8 givenname: Aldemar surname: Degroot fullname: Degroot, Aldemar – sequence: 9 givenname: Jeffrey M. surname: Witkin fullname: Witkin, Jeffrey M. email: witkinconsult@gmail.com |
| BookMark | eNp9kUFP3DAQha2KSl1of0BvOfZAgsdJ7EQ9IUS7SEi90LPldcasV4md2g4CfkR_cx2WXjhwssZ63xvNe6fkxHmHhHwFWgEFfnGodrtQMQpdBayi0H8gG-gEK0Xb9CdkkzW8bGrWfSKnMR4opQ1tYUP-Xj-ocVHJeld4U7Tl9k4UATXOyYdCuaTuvbNxKkwe0x6LFFClCV1a5co9WkxP58WAc8AYs8t5_hyKqPf22c_7gM6qzAW_3O9f-CXiSv5fUQ5orLar32Q1fiYfjRojfnl9z8jvH9d3V9vy9tfPm6vL21LXjKcSoTdN39MGhh03zHRmEB1lCI2Alve9YbViPQVjalPzTnFes7rbccGzBsVQn5FvR985-D8LxiQnGzWOo3LolygZtIK3QDuepeIo1cHHGNBIbdNLYCkoO0qgcm1AHmRuQK4NSGAyN5BJeEPOwU4qPL3LfD8ymK9_sBhkXNPRONgcWZKDt-_Q_wCE3aIg |
| CitedBy_id | crossref_primary_10_1016_j_neuint_2023_105566 crossref_primary_10_2174_1389450124666230425233727 crossref_primary_10_3390_ijms22031351 crossref_primary_10_1016_j_bbr_2020_112932 crossref_primary_10_3390_ijms21020505 crossref_primary_10_1016_j_bmc_2020_115578 crossref_primary_10_3390_ijms242216416 crossref_primary_10_1016_j_pbb_2024_173858 crossref_primary_10_1016_j_bmcl_2021_128028 crossref_primary_10_1097_WNR_0000000000001437 crossref_primary_10_1111_pcn_12852 crossref_primary_10_3389_fnbeh_2019_00208 crossref_primary_10_3390_ph16020175 crossref_primary_10_1021_acschemneuro_0c00554 crossref_primary_10_1017_neu_2021_47 crossref_primary_10_1523_JNEUROSCI_2393_23_2024 crossref_primary_10_1007_s11055_022_01213_7 crossref_primary_10_1097_JCP_0000000000001768 crossref_primary_10_1016_j_bbrc_2019_08_061 crossref_primary_10_1038_s41386_020_0775_z crossref_primary_10_21518_ms2024_297 crossref_primary_10_2174_0122115560281804240102054639 |
| Cites_doi | 10.1016/j.bbr.2010.01.022 10.1124/mol.106.024612 10.1016/S0893-133X(99)00041-X 10.2174/138945009789735129 10.1016/j.bbr.2009.03.011 10.1016/j.biopsych.2006.12.011 10.1016/j.ejphar.2008.08.026 10.1523/JNEUROSCI.23-20-07451.2003 10.3233/JAD-151146 10.1124/jpet.107.119404 10.1016/j.biopsych.2005.05.012 10.1016/S0091-3057(01)00744-4 10.4049/jimmunol.1201887 10.1016/j.ejphar.2006.09.064 10.1016/j.pharep.2016.04.002 10.1021/jm030030n 10.1016/j.nlm.2016.10.011 10.1016/j.nbd.2017.07.005 10.1017/S1461145711001027 10.1016/j.tips.2004.07.002 10.1038/266730a0 10.1111/cns.12698 10.1515/revneuro-2013-0066 10.1073/pnas.90.18.8547 10.1007/s00213-009-1626-0 10.1016/j.euroneuro.2015.10.003 10.1016/j.neuropharm.2012.06.061 10.1515/revneuro-2014-0017 10.1016/j.neuropharm.2004.11.015 10.1007/s00213-003-1618-4 10.1016/S0021-9258(19)49479-9 10.1016/j.pharep.2017.01.030 10.1016/S0149-7634(97)00053-5 10.1016/S0021-9258(17)46830-X 10.1111/j.1460-9568.2004.03288.x 10.1007/s00213-009-1521-8 10.1016/S0006-8993(02)02965-7 10.1097/FBP.0b013e3282f62d8c 10.1007/s10549-016-4027-1 10.1177/0269881115609072 10.1016/0896-6273(93)90149-L 10.1038/sj.bjp.0703357 10.1371/journal.pone.0142499 10.1007/s00213-005-0169-2 10.1002/hipo.20938 10.1073/pnas.0337340100 10.1124/jpet.106.103143 10.1016/j.neuropharm.2006.04.017 10.1016/j.neubiorev.2005.03.017 10.1016/j.eplepsyres.2007.03.017 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1016/j.bbr.2018.12.019 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1872-7549 |
| EndPage | 278 |
| ExternalDocumentID | 10_1016_j_bbr_2018_12_019 S0166432818309677 |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 6J9 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAXLA AAXUO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM L7B M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSN SSZ T5K TEORI TN5 WH7 YR2 ~G- .GJ 41~ 5VS AAQFI AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACRPL ACVFH ADCNI ADIYS ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGHFR AGQPQ AGRNS AHHHB AI. AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMQ HVGLF HZ~ R2- SEW SNS SSH VH1 WUQ XJT ZGI ZXP ZY4 7X8 ACLOT EFKBS ~HD |
| ID | FETCH-LOGICAL-c326t-e19f499041db6f2f8fd7802e14715699f23a2901ff3f368a663238b6762e1e7d3 |
| IEDL.DBID | AIKHN |
| ISSN | 0166-4328 1872-7549 |
| IngestDate | Sat Sep 27 19:58:47 EDT 2025 Thu Apr 24 23:12:06 EDT 2025 Tue Jul 01 02:19:33 EDT 2025 Fri Feb 23 02:32:39 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Schizophrenia Depression Anxiety 5-HT7 receptors 5-HT receptor knockout |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-e19f499041db6f2f8fd7802e14715699f23a2901ff3f368a663238b6762e1e7d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PQID | 2157651086 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2157651086 crossref_citationtrail_10_1016_j_bbr_2018_12_019 crossref_primary_10_1016_j_bbr_2018_12_019 elsevier_sciencedirect_doi_10_1016_j_bbr_2018_12_019 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-15 |
| PublicationDateYYYYMMDD | 2019-03-15 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationTitle | Behavioural brain research |
| PublicationYear | 2019 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Dulawa, Hen (bib0035) 2005; 29 Jaeschke, Sowa-Kućma, Pańczyszyn-Trzewik, Misztak, Styczeń, Datka (bib0115) 2016; 68 Witkin, Morrow, Li (bib0250) 2004; 172 Zareifopoulos, Papatheodoropoulos (bib0260) 2016; 136 Wesolowska, Nikiforuk, Stachowicz, Tatarczynska (bib0240) 2006; 51 Bonaventure, Kelly, Aluisio, Shelton, Lord, Galici, Miller, Atack, Lovenberg, Dugovic (bib0020) 2007; 321 Bard, Zgombick, Adham, Vaysse, Branchek, Weinshank (bib0015) 1993; 268 Semenova, Geyer, Sutcliffe, Markou, Hedlund (bib0210) 2008; 63 Terrón (bib0235) 2014; 25 Kim, Bridle, Ghia, Wang, Syed, Manocha, Rengasamy, Shajib, Wan, Hedlund, Khan (bib0120) 2013; 190 Witkin, Baez, Yu, Barton, Shannon (bib0255) 2007; 75 Maxwell, Gleason, Falcone, Svensson, Balcer, Li, Witkin (bib0140) 2018; 59 Sowa-Kućma, Pańczyszyn-Trzewik, Misztak, Jaeschke, Sendek, Styczeń, Datka, Koperny (bib0225) 2017; 69 Wesolowska, Nikiforuk, Stachowicz (bib0245) 2006; 553 Mnie-Filali, Lambas-Señas, Scarna, Haddjeri (bib0145) 2009; 10 Roberts, Hedlund (bib0175) 2012; 22 Hedlund (bib0090) 2009; 206 Hedlund, Danielson, Thomas, Slanina, Carson, Sutcliffe (bib0095) 2003; 100 Nelson, Young (bib0155) 1998; 22 Glass, Grossman, Farnbauch, DiNardo (bib0070) 2003; 23 Sarkisyan, Hedlund (bib0200) 2009; 202 Glennon (bib0075) 2003; 46 Stroth, Svenningsson (bib0230) 2015; 25 Hagan, Price, Jeffrey, Deeks, Stean, Piper, Smith, Upton, Medhurst, Middlemiss, Riley, Lovell, Bromidge, Thomas (bib0060) 2000; 130 Galici, Boggs, Miller, Bonaventure, Atack (bib0065) 2008; 19 Degroot, Treit (bib0030) 2002; 949 Hedlund, Sutcliffe (bib0100) 2004; 25 Pouzet, Didriksen, Arnt (bib0165) 2002; 71 Ruat, Traiffort, Leurs, Tardivel-Lacombe, Diaz, Arrang, Schwartz (bib0190) 1993; 90 Rorick-Kehn, Hart, McKinzie (bib0185) 2005; 183 Eriksson, Golkar, Ekström, Svenningsson, Ogren (bib0040) 2008; 596 Pytka, Partyka, Jastrzębska-Więsek, Siwek, Głuch-Lutwin, Mordyl, Kazek, Rapacz, Olczyk, Gałuszka, Błachuta, Waszkielewicz, Marona, Sapa, Besołowska (bib0170) 2015; 10 Shen, Monsma, Metcalf, Jose, Hamblin, Sibley (bib0215) 1993; 25 Hedlund, Huitron-Resendiz, Henriksen, Sutcliffe (bib0105) 2005; 58 Eriksson, Golkar, Ekström, Svenningsson, Ogren (bib0045) 2012; 63 Lovenberg, Baron, de Lecea, Miller, Prosser, Rea, Foye, Racke, Slone, Siegel, Danielson, Sutcliffe, Erlander (bib0135) 1993; 11 Mullins, Gianutsos, Eison (bib0150) 1999; 21 Delcourte, Abrial, Etiévant, Rovera, Arnt, Didriksen, Haddjeri (bib0025) 2017; 23 Sarkisyan, Roberts, Hedlund (bib0205) 2010; 209 Santello, Bisco, Nevian, Lacivita, Leopoldo, Nevian (bib0195) 2017; 106 Ivachtchenko, Lavrovsky, Okun (bib0110) 2016; 53 Roberts, Krucker, Levy, Slanina, Sutcliffe, Hedlund (bib0180) 2004; 19 Li, Need, Baez, Witkin (bib0130) 2006; 319 Porsolt, Le Pichon, Jalfre (bib0160) 1977; 266 Abbas, Hedlund, Huang, Tran, Meltzer, Roth (bib0005) 2009; 205 Hauser, Hedlund, Roberts, Sari, Bell, Engleman (bib0085) 2015; 13 Alvarez, Perez, Dragheim, Loft, Artigas (bib0010) 2012; 15 Guscott, Bristow, Hadingham, Rosahl, Beer, Stanton, Bromidge, Owens, Huscroft, Myers, Rupniak, Patel, Whiting, Hutson, Fone, Biello, Kulagowski, McAllister (bib0080) 2005; 48 Gasbarri, Pompili (bib0055) 2014; 25 Gautam, Bae, Kim (bib0050) 2017; 161 Smith, Rahman, Toohey, Mazurkiewicz, Herrick-Davis, Teitler (bib0220) 2006; 70 Köhler, Cierpinsky, Kronenberg, Adli (bib0125) 2016; 30 Roberts (10.1016/j.bbr.2018.12.019_bib0175) 2012; 22 Hagan (10.1016/j.bbr.2018.12.019_bib0060) 2000; 130 Glennon (10.1016/j.bbr.2018.12.019_bib0075) 2003; 46 Eriksson (10.1016/j.bbr.2018.12.019_bib0045) 2012; 63 Witkin (10.1016/j.bbr.2018.12.019_bib0250) 2004; 172 Pytka (10.1016/j.bbr.2018.12.019_bib0170) 2015; 10 Porsolt (10.1016/j.bbr.2018.12.019_bib0160) 1977; 266 Hauser (10.1016/j.bbr.2018.12.019_bib0085) 2015; 13 Delcourte (10.1016/j.bbr.2018.12.019_bib0025) 2017; 23 Abbas (10.1016/j.bbr.2018.12.019_bib0005) 2009; 205 Bard (10.1016/j.bbr.2018.12.019_bib0015) 1993; 268 Mnie-Filali (10.1016/j.bbr.2018.12.019_bib0145) 2009; 10 Pouzet (10.1016/j.bbr.2018.12.019_bib0165) 2002; 71 Bonaventure (10.1016/j.bbr.2018.12.019_bib0020) 2007; 321 Rorick-Kehn (10.1016/j.bbr.2018.12.019_bib0185) 2005; 183 Semenova (10.1016/j.bbr.2018.12.019_bib0210) 2008; 63 Galici (10.1016/j.bbr.2018.12.019_bib0065) 2008; 19 Hedlund (10.1016/j.bbr.2018.12.019_bib0105) 2005; 58 Mullins (10.1016/j.bbr.2018.12.019_bib0150) 1999; 21 Smith (10.1016/j.bbr.2018.12.019_bib0220) 2006; 70 Degroot (10.1016/j.bbr.2018.12.019_bib0030) 2002; 949 Glass (10.1016/j.bbr.2018.12.019_bib0070) 2003; 23 Sowa-Kućma (10.1016/j.bbr.2018.12.019_bib0225) 2017; 69 Terrón (10.1016/j.bbr.2018.12.019_bib0235) 2014; 25 Gautam (10.1016/j.bbr.2018.12.019_bib0050) 2017; 161 Ruat (10.1016/j.bbr.2018.12.019_bib0190) 1993; 90 Alvarez (10.1016/j.bbr.2018.12.019_bib0010) 2012; 15 Wesolowska (10.1016/j.bbr.2018.12.019_bib0240) 2006; 51 Hedlund (10.1016/j.bbr.2018.12.019_bib0095) 2003; 100 Jaeschke (10.1016/j.bbr.2018.12.019_bib0115) 2016; 68 Roberts (10.1016/j.bbr.2018.12.019_bib0180) 2004; 19 Stroth (10.1016/j.bbr.2018.12.019_bib0230) 2015; 25 Gasbarri (10.1016/j.bbr.2018.12.019_bib0055) 2014; 25 Witkin (10.1016/j.bbr.2018.12.019_bib0255) 2007; 75 Maxwell (10.1016/j.bbr.2018.12.019_bib0140) 2018; 59 Sarkisyan (10.1016/j.bbr.2018.12.019_bib0200) 2009; 202 Wesolowska (10.1016/j.bbr.2018.12.019_bib0245) 2006; 553 Eriksson (10.1016/j.bbr.2018.12.019_bib0040) 2008; 596 Kim (10.1016/j.bbr.2018.12.019_bib0120) 2013; 190 Ivachtchenko (10.1016/j.bbr.2018.12.019_bib0110) 2016; 53 Hedlund (10.1016/j.bbr.2018.12.019_bib0090) 2009; 206 Santello (10.1016/j.bbr.2018.12.019_bib0195) 2017; 106 Köhler (10.1016/j.bbr.2018.12.019_bib0125) 2016; 30 Lovenberg (10.1016/j.bbr.2018.12.019_bib0135) 1993; 11 Guscott (10.1016/j.bbr.2018.12.019_bib0080) 2005; 48 Dulawa (10.1016/j.bbr.2018.12.019_bib0035) 2005; 29 Sarkisyan (10.1016/j.bbr.2018.12.019_bib0205) 2010; 209 Li (10.1016/j.bbr.2018.12.019_bib0130) 2006; 319 Nelson (10.1016/j.bbr.2018.12.019_bib0155) 1998; 22 Hedlund (10.1016/j.bbr.2018.12.019_bib0100) 2004; 25 Shen (10.1016/j.bbr.2018.12.019_bib0215) 1993; 25 Zareifopoulos (10.1016/j.bbr.2018.12.019_bib0260) 2016; 136 |
| References_xml | – volume: 206 start-page: 345 year: 2009 end-page: 354 ident: bib0090 article-title: The 5-HT publication-title: Psychopharmacology (Berl.) – volume: 90 year: 1993 ident: bib0190 article-title: Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 25 start-page: 481 year: 2004 end-page: 486 ident: bib0100 article-title: Functional, molecular and pharmacological advances in 5-HT publication-title: Trends Pharamacol. Sci. – volume: 15 start-page: 589 year: 2012 end-page: 600 ident: bib0010 article-title: A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder publication-title: Int. J. Neuropsychopharmacol. – volume: 202 start-page: 26 year: 2009 end-page: 31 ident: bib0200 article-title: The 5-HT7 receptor is involved in allocentric spatial memory information processing publication-title: Behav Brain Res. – volume: 596 start-page: 107 year: 2008 end-page: 110 ident: bib0040 article-title: 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice publication-title: Eur. J. Pharmacol. – volume: 71 start-page: 655 year: 2002 end-page: 665 ident: bib0165 article-title: Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia publication-title: Pharmacol. Biochem. Behav. – volume: 268 start-page: 23422 year: 1993 end-page: 23426 ident: bib0015 article-title: Cloning of a novel human serotonin receptor (5-HT publication-title: J. Biol. Chem. – volume: 100 start-page: 1375 year: 2003 end-page: 1380 ident: bib0095 article-title: No hypothermic response to serotonin in 5-HT7 receptor knockout mice publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 59 start-page: 467 year: 2018 end-page: 473 ident: bib0140 article-title: Effects of 5-HT publication-title: Behav. Brain Res. – volume: 75 start-page: 39 year: 2007 end-page: 45 ident: bib0255 article-title: Constitutive deletion of the serotonin-7 (5-HT publication-title: Epilepsy Res. – volume: 553 start-page: 185 year: 2006 end-page: 190 ident: bib0245 article-title: Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats publication-title: Eur. J. Pharmacol. – volume: 63 start-page: 98 year: 2008 end-page: 105 ident: bib0210 article-title: Inactivation of the 5-HT7 receptor partially blocks PCP-induced disruption of prepulse inhibition publication-title: Biol. Psychiatry – volume: 68 start-page: 748 year: 2016 end-page: 755 ident: bib0115 article-title: Lurasidone: the 2016 update on the pharmacology, efficacy and safety profile publication-title: Pharmacol. Rep. – volume: 25 start-page: 311 year: 2014 end-page: 323 ident: bib0055 article-title: Serotonergic 5-HT7 receptors and cognition publication-title: Rev. Neurosci. – volume: 949 start-page: 60 year: 2002 end-page: 70 ident: bib0030 article-title: Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests publication-title: Brain Res. – volume: 205 start-page: 119 year: 2009 end-page: 128 ident: bib0005 article-title: Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo publication-title: Psychopharmacology (Berl.) – volume: 106 start-page: 214 year: 2017 end-page: 221 ident: bib0195 article-title: The brain-penetrant 5-HT publication-title: Neurobiol. Dis. – volume: 19 start-page: 1913 year: 2004 end-page: 1922 ident: bib0180 article-title: Mice lacking 5-HT7 receptors show specific impairments in contextual learning publication-title: Eur. J. Neurosci. – volume: 183 start-page: 226 year: 2005 end-page: 240 ident: bib0185 article-title: Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands publication-title: Psychopharmacology (Berl.) – volume: 48 start-page: 492 year: 2005 end-page: 502 ident: bib0080 article-title: Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression publication-title: Neuropharmacology – volume: 10 start-page: 1109 year: 2009 end-page: 1117 ident: bib0145 article-title: Therapeutic potential of 5-HT7 receptors in mood disorders publication-title: Curr. Drug Targets – volume: 319 start-page: 254 year: 2006 end-page: 259 ident: bib0130 article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice publication-title: J. Pharmacol. Exp. Ther. – volume: 53 start-page: 583 year: 2016 end-page: 620 ident: bib0110 article-title: AVN-101: a multi-target drug candidate for the treatment of CNS disorders publication-title: J. Alzheimers Dis. – volume: 172 start-page: 52 year: 2004 end-page: 57 ident: bib0250 article-title: A rapid experimental conflict procedure for detection of anxiolytic compounds in mice publication-title: Psychopharmacology – volume: 23 start-page: 518 year: 2017 end-page: 525 ident: bib0025 article-title: Asenapine modulates mood-related behaviors and 5-HT publication-title: CNS Neurosci. Ther. – volume: 25 start-page: 2372 year: 2015 end-page: 2380 ident: bib0230 article-title: S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior publication-title: Eur. Neuropsychopharmacol. – volume: 161 start-page: 29 year: 2017 end-page: 40 ident: bib0050 article-title: Up-regulation of cathepsin S expression by HSP90 and 5-HT publication-title: Breast Cancer Res. Treat. – volume: 30 start-page: 13 year: 2016 end-page: 22 ident: bib0125 article-title: The serotonergic system in the neurobiology of depression: relevance for novel antidepressants publication-title: J. Psychopharmacol. – volume: 19 start-page: 153 year: 2008 end-page: 159 ident: bib0065 article-title: Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity publication-title: Behav. Pharmacol. – volume: 63 start-page: 1150 year: 2012 end-page: 1160 ident: bib0045 article-title: 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors publication-title: Neuropharmacology – volume: 58 start-page: 831 year: 2005 end-page: 837 ident: bib0105 article-title: 5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern publication-title: Biol. Psychiatry – volume: 130 start-page: 539 year: 2000 end-page: 548 ident: bib0060 article-title: Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist publication-title: Br. J. Pharmacol. – volume: 190 start-page: 4795 year: 2013 end-page: 47804 ident: bib0120 article-title: Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation publication-title: J. Immunol. – volume: 22 start-page: 453 year: 1998 end-page: 462 ident: bib0155 article-title: Behavior in mice with targeted disruption of single genes publication-title: Neurosci. Biobehav. Rev. – volume: 136 start-page: 204 year: 2016 end-page: 209 ident: bib0260 article-title: Effects of 5-HT-7 receptor ligands on memory and cognition publication-title: Neurobiol. Learn. Mem. – volume: 70 start-page: 1264 year: 2006 end-page: 1270 ident: bib0220 article-title: Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor publication-title: Mol. Pharmacol. – volume: 21 start-page: 352 year: 1999 end-page: 367 ident: bib0150 article-title: Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus publication-title: Neuropsychopharmacology – volume: 10 year: 2015 ident: bib0170 article-title: Antidepressant- and anxiolytic-like effects of new dual 5-HT₁A and 5-HT₇ antagonists in animal models publication-title: PLoS One – volume: 51 start-page: 578 year: 2006 end-page: 586 ident: bib0240 article-title: Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression publication-title: Neuropharmacology – volume: 69 start-page: 595 year: 2017 end-page: 601 ident: bib0225 article-title: Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant publication-title: Pharmacol. Rep. – volume: 13 start-page: 448 year: 2015 ident: bib0085 article-title: The 5-HT7 receptor as a potential target for treating drug and alcohol abuse publication-title: Front. Neurosci. – volume: 29 start-page: 771 year: 2005 end-page: 783 ident: bib0035 article-title: Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test publication-title: Neurosci. Biobehav. Rev. – volume: 25 start-page: 18200 year: 1993 end-page: 18204 ident: bib0215 article-title: Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype publication-title: J. Biol. Chem. – volume: 22 start-page: 762 year: 2012 end-page: 771 ident: bib0175 article-title: The 5-HT(7) receptor in learning and memory publication-title: Hippocampus – volume: 11 start-page: 449 year: 1993 end-page: 458 ident: bib0135 article-title: A novel adenylyl cyclase-activating serotonin receptor (5-HT publication-title: Neuron – volume: 266 start-page: 730 year: 1977 end-page: 732 ident: bib0160 article-title: Depression: a new animal model sensitive to antidepressant treatments publication-title: Nature – volume: 46 start-page: 1 year: 2003 end-page: 18 ident: bib0075 article-title: Higher-end serotonin receptors: 5-HT publication-title: J. Med. Chem. – volume: 25 start-page: 439 year: 2014 end-page: 449 ident: bib0235 article-title: Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders publication-title: Rev. Neurosci. – volume: 23 start-page: 7451 year: 2003 end-page: 7460 ident: bib0070 article-title: Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus publication-title: J. Neurosci. – volume: 321 start-page: 690 year: 2007 end-page: 698 ident: bib0020 article-title: Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents publication-title: J. Pharmacol. Exp. Ther. – volume: 209 start-page: 99 year: 2010 end-page: 108 ident: bib0205 article-title: The 5HT(7) receptor as a mediator and modulator of antidepressant-like behavior publication-title: Behav. Brain Res. – volume: 209 start-page: 99 year: 2010 ident: 10.1016/j.bbr.2018.12.019_bib0205 article-title: The 5HT(7) receptor as a mediator and modulator of antidepressant-like behavior publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2010.01.022 – volume: 70 start-page: 1264 year: 2006 ident: 10.1016/j.bbr.2018.12.019_bib0220 article-title: Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor publication-title: Mol. Pharmacol. doi: 10.1124/mol.106.024612 – volume: 21 start-page: 352 year: 1999 ident: 10.1016/j.bbr.2018.12.019_bib0150 article-title: Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(99)00041-X – volume: 10 start-page: 1109 year: 2009 ident: 10.1016/j.bbr.2018.12.019_bib0145 article-title: Therapeutic potential of 5-HT7 receptors in mood disorders publication-title: Curr. Drug Targets doi: 10.2174/138945009789735129 – volume: 202 start-page: 26 year: 2009 ident: 10.1016/j.bbr.2018.12.019_bib0200 article-title: The 5-HT7 receptor is involved in allocentric spatial memory information processing publication-title: Behav Brain Res. doi: 10.1016/j.bbr.2009.03.011 – volume: 63 start-page: 98 year: 2008 ident: 10.1016/j.bbr.2018.12.019_bib0210 article-title: Inactivation of the 5-HT7 receptor partially blocks PCP-induced disruption of prepulse inhibition publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.12.011 – volume: 596 start-page: 107 year: 2008 ident: 10.1016/j.bbr.2018.12.019_bib0040 article-title: 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2008.08.026 – volume: 23 start-page: 7451 year: 2003 ident: 10.1016/j.bbr.2018.12.019_bib0070 article-title: Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-20-07451.2003 – volume: 53 start-page: 583 year: 2016 ident: 10.1016/j.bbr.2018.12.019_bib0110 article-title: AVN-101: a multi-target drug candidate for the treatment of CNS disorders publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-151146 – volume: 321 start-page: 690 year: 2007 ident: 10.1016/j.bbr.2018.12.019_bib0020 article-title: Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.107.119404 – volume: 58 start-page: 831 year: 2005 ident: 10.1016/j.bbr.2018.12.019_bib0105 article-title: 5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2005.05.012 – volume: 71 start-page: 655 year: 2002 ident: 10.1016/j.bbr.2018.12.019_bib0165 article-title: Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/S0091-3057(01)00744-4 – volume: 190 start-page: 4795 year: 2013 ident: 10.1016/j.bbr.2018.12.019_bib0120 article-title: Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation publication-title: J. Immunol. doi: 10.4049/jimmunol.1201887 – volume: 553 start-page: 185 year: 2006 ident: 10.1016/j.bbr.2018.12.019_bib0245 article-title: Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2006.09.064 – volume: 68 start-page: 748 year: 2016 ident: 10.1016/j.bbr.2018.12.019_bib0115 article-title: Lurasidone: the 2016 update on the pharmacology, efficacy and safety profile publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2016.04.002 – volume: 46 start-page: 1 year: 2003 ident: 10.1016/j.bbr.2018.12.019_bib0075 article-title: Higher-end serotonin receptors: 5-HT5, 5-HT6 and 5-HT7 publication-title: J. Med. Chem. doi: 10.1021/jm030030n – volume: 136 start-page: 204 year: 2016 ident: 10.1016/j.bbr.2018.12.019_bib0260 article-title: Effects of 5-HT-7 receptor ligands on memory and cognition publication-title: Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2016.10.011 – volume: 106 start-page: 214 year: 2017 ident: 10.1016/j.bbr.2018.12.019_bib0195 article-title: The brain-penetrant 5-HT7 receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2017.07.005 – volume: 59 start-page: 467 year: 2018 ident: 10.1016/j.bbr.2018.12.019_bib0140 article-title: Effects of 5-HT7 receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophrenia publication-title: Behav. Brain Res. – volume: 15 start-page: 589 year: 2012 ident: 10.1016/j.bbr.2018.12.019_bib0010 article-title: A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder publication-title: Int. J. Neuropsychopharmacol. doi: 10.1017/S1461145711001027 – volume: 25 start-page: 481 year: 2004 ident: 10.1016/j.bbr.2018.12.019_bib0100 article-title: Functional, molecular and pharmacological advances in 5-HT7 receptor research publication-title: Trends Pharamacol. Sci. doi: 10.1016/j.tips.2004.07.002 – volume: 266 start-page: 730 year: 1977 ident: 10.1016/j.bbr.2018.12.019_bib0160 article-title: Depression: a new animal model sensitive to antidepressant treatments publication-title: Nature doi: 10.1038/266730a0 – volume: 23 start-page: 518 year: 2017 ident: 10.1016/j.bbr.2018.12.019_bib0025 article-title: Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission publication-title: CNS Neurosci. Ther. doi: 10.1111/cns.12698 – volume: 25 start-page: 311 year: 2014 ident: 10.1016/j.bbr.2018.12.019_bib0055 article-title: Serotonergic 5-HT7 receptors and cognition publication-title: Rev. Neurosci. doi: 10.1515/revneuro-2013-0066 – volume: 90 year: 1993 ident: 10.1016/j.bbr.2018.12.019_bib0190 article-title: Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.90.18.8547 – volume: 206 start-page: 345 year: 2009 ident: 10.1016/j.bbr.2018.12.019_bib0090 article-title: The 5-HT7 receptor and disorders of the nervous system: an overview publication-title: Psychopharmacology (Berl.) doi: 10.1007/s00213-009-1626-0 – volume: 25 start-page: 2372 year: 2015 ident: 10.1016/j.bbr.2018.12.019_bib0230 article-title: S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.10.003 – volume: 63 start-page: 1150 year: 2012 ident: 10.1016/j.bbr.2018.12.019_bib0045 article-title: 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.06.061 – volume: 25 start-page: 439 year: 2014 ident: 10.1016/j.bbr.2018.12.019_bib0235 article-title: Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders publication-title: Rev. Neurosci. doi: 10.1515/revneuro-2014-0017 – volume: 48 start-page: 492 year: 2005 ident: 10.1016/j.bbr.2018.12.019_bib0080 article-title: Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.11.015 – volume: 172 start-page: 52 year: 2004 ident: 10.1016/j.bbr.2018.12.019_bib0250 article-title: A rapid experimental conflict procedure for detection of anxiolytic compounds in mice publication-title: Psychopharmacology doi: 10.1007/s00213-003-1618-4 – volume: 268 start-page: 23422 year: 1993 ident: 10.1016/j.bbr.2018.12.019_bib0015 article-title: Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)49479-9 – volume: 69 start-page: 595 year: 2017 ident: 10.1016/j.bbr.2018.12.019_bib0225 article-title: Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2017.01.030 – volume: 22 start-page: 453 year: 1998 ident: 10.1016/j.bbr.2018.12.019_bib0155 article-title: Behavior in mice with targeted disruption of single genes publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/S0149-7634(97)00053-5 – volume: 25 start-page: 18200 year: 1993 ident: 10.1016/j.bbr.2018.12.019_bib0215 article-title: Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)46830-X – volume: 19 start-page: 1913 year: 2004 ident: 10.1016/j.bbr.2018.12.019_bib0180 article-title: Mice lacking 5-HT7 receptors show specific impairments in contextual learning publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2004.03288.x – volume: 205 start-page: 119 year: 2009 ident: 10.1016/j.bbr.2018.12.019_bib0005 article-title: Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo publication-title: Psychopharmacology (Berl.) doi: 10.1007/s00213-009-1521-8 – volume: 949 start-page: 60 year: 2002 ident: 10.1016/j.bbr.2018.12.019_bib0030 article-title: Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests publication-title: Brain Res. doi: 10.1016/S0006-8993(02)02965-7 – volume: 19 start-page: 153 year: 2008 ident: 10.1016/j.bbr.2018.12.019_bib0065 article-title: Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity publication-title: Behav. Pharmacol. doi: 10.1097/FBP.0b013e3282f62d8c – volume: 161 start-page: 29 year: 2017 ident: 10.1016/j.bbr.2018.12.019_bib0050 article-title: Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-016-4027-1 – volume: 30 start-page: 13 year: 2016 ident: 10.1016/j.bbr.2018.12.019_bib0125 article-title: The serotonergic system in the neurobiology of depression: relevance for novel antidepressants publication-title: J. Psychopharmacol. doi: 10.1177/0269881115609072 – volume: 11 start-page: 449 issue: 1993 year: 1993 ident: 10.1016/j.bbr.2018.12.019_bib0135 article-title: A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms publication-title: Neuron doi: 10.1016/0896-6273(93)90149-L – volume: 130 start-page: 539 year: 2000 ident: 10.1016/j.bbr.2018.12.019_bib0060 article-title: Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703357 – volume: 10 year: 2015 ident: 10.1016/j.bbr.2018.12.019_bib0170 article-title: Antidepressant- and anxiolytic-like effects of new dual 5-HT₁A and 5-HT₇ antagonists in animal models publication-title: PLoS One doi: 10.1371/journal.pone.0142499 – volume: 183 start-page: 226 year: 2005 ident: 10.1016/j.bbr.2018.12.019_bib0185 article-title: Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands publication-title: Psychopharmacology (Berl.) doi: 10.1007/s00213-005-0169-2 – volume: 22 start-page: 762 year: 2012 ident: 10.1016/j.bbr.2018.12.019_bib0175 article-title: The 5-HT(7) receptor in learning and memory publication-title: Hippocampus doi: 10.1002/hipo.20938 – volume: 100 start-page: 1375 year: 2003 ident: 10.1016/j.bbr.2018.12.019_bib0095 article-title: No hypothermic response to serotonin in 5-HT7 receptor knockout mice publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0337340100 – volume: 319 start-page: 254 year: 2006 ident: 10.1016/j.bbr.2018.12.019_bib0130 article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.106.103143 – volume: 51 start-page: 578 year: 2006 ident: 10.1016/j.bbr.2018.12.019_bib0240 article-title: Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.04.017 – volume: 29 start-page: 771 year: 2005 ident: 10.1016/j.bbr.2018.12.019_bib0035 article-title: Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2005.03.017 – volume: 75 start-page: 39 year: 2007 ident: 10.1016/j.bbr.2018.12.019_bib0255 article-title: Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds publication-title: Epilepsy Res. doi: 10.1016/j.eplepsyres.2007.03.017 – volume: 13 start-page: 448 year: 2015 ident: 10.1016/j.bbr.2018.12.019_bib0085 article-title: The 5-HT7 receptor as a potential target for treating drug and alcohol abuse publication-title: Front. Neurosci. |
| SSID | ssj0004051 |
| Score | 2.3935895 |
| Snippet | The 5-HT7 receptor is the most recently identified receptor subtype within a family of 5-HT receptors activated by the neurotransmitter serotonin. There has... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 270 |
| SubjectTerms | 5-HT receptor knockout 5-HT7 receptors Anxiety Depression Schizophrenia |
| Title | Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice |
| URI | https://dx.doi.org/10.1016/j.bbr.2018.12.019 https://www.proquest.com/docview/2157651086 |
| Volume | 360 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BuXBBrKJsMhLigGoaZ8-xqqgKiF4AqTfLiW1URNOKthJc-AS-mZk0KYsQB46JMlk8zrxn-3kG4CRCWDVa-zyLNC0zCo-nqTDczzLHuDrRNqTNyTe9sHvvX_WD_hK0q70wJKssY_88phfRujzTLFuzOR4MmrdIVhBOKZuRhzw8ipZhxUW0j2uw0rq87vY-t0c6wbwsYRhyMqgWNwuZV5pSVlARF5OClG_nd3j6EagL9Omsw1pJG1lr_mYbsGTyTdhq5ThkHr6yU1YIOYsZ8i14v1hk8GYjywLevYsYfqQZ4_iaYUuqB_yRJ0OGfJUh_2MLsTldrvIXknE22EIjmzfwpGaTr_I8Vtb3KexnE0OW1SO4NpSWgu5Hte634b5zcdfu8rLsAs-Qy025EYnFcZDjC9qi59rY6ih2XCMQx4IwSazrKVp9tdazXhgr5CyI-2mIYdUIE2lvB2r5KDe7wIywAQ6ZUms8z1cBQaGLXcBXCuOGUHEdnKq1ZVbmJKfSGE-yEp89SnSQJAdJ4Up0UB3OFibjeUKOvy72KxfKb71KImD8ZXZcuVvi30ZLKCo3o9lEIkGKwoCqU-3979b7sIpHCanYRHAAtenzzBwirZmmR7B8_iaOys77AUF-974 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1Be4ALYhU7RkIcEFbj7DlWFShsvVAkbpYT26gI0oq2EvwE38xMmpRFiANXx-MkHnvm2X6eATiK0K0arX2eR5qOGYXHs0wY7ue5Y1ydaBvS5eSbbpje-Zf3wf0cdOq7MESrrGz_1KaX1roqaVW92Rr2-61bBCvoTimakYc4PIrmoelTUusGNNsXV2n383qkE0zTEoYhJ4H6cLOkeWUZRQUVcbkpSPF2fndPPwx16X3Ol2Gpgo2sPf2yFZgzxSqstQtcMj-_sWNWEjnLHfI1eD-bRfBmA8sCnvYihj9phri-ZtiT6gEn8uiZIV5liP_YjGxO1VXxSjTOUzbjyBanWKjZ6Cs9j1X5fUr5yciQZP0Krg2FpaD2KNf9Otydn_U6Ka_SLvAcsdyYG5FYXAc5vqAreq6NrY5ixzUC_VgQJol1PUWnr9Z61gtjhZgF_X4Wolk1wkTa24BGMSjMJjAjbIBLpswaz_NVQK7QxSHgK4V2Q6h4C5y6t2VexSSn1BhPsiafPUpUkCQFSeFKVNAWnMxEhtOAHH9V9msVym-jSqLD-EvssFa3xNlGRyiqMIPJSCJAisKAslNt_6_pA1hIezfX8vqie7UDi_gkIUabCHahMX6ZmD2EOONsvxrCHxge-aQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+5-HT7+receptor+antagonism+for+the+treatment+of+anxiety%2C+depression%2C+and+schizophrenia+through+the+use+of+receptor-deficient+mice&rft.jtitle=Behavioural+brain+research&rft.au=Balcer%2C+Olivia+M.&rft.au=Seager%2C+Matthew+A.&rft.au=Gleason%2C+Scott+D.&rft.au=Li%2C+Xia&rft.date=2019-03-15&rft.issn=0166-4328&rft.volume=360&rft.spage=270&rft.epage=278&rft_id=info:doi/10.1016%2Fj.bbr.2018.12.019&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbr_2018_12_019 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0166-4328&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0166-4328&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0166-4328&client=summon |